Policy | July 02, 2025
India exports US$ 4,961 million pharmaceutical during April–May 2025: Pharmexcil
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Label updates reflect growing body of real-world evidence and regulatory confidence in the safety profile of the class of CD19- and BCMA-directed autologous CAR T cell therapies, reinforcing efforts to increase equitable access
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Now approved for both acute and chronic HCV in adults and children aged 3 and above
Subscribe To Our Newsletter & Stay Updated
